U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs
The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening an effort […]
Health
The deadly cancer hiding in plain sight — and why most patients never get screened
NEWYou can now listen to Fox News articles! A new study from Northwestern Medicine suggests that current lung cancer screening
New Study Links Sleep Apnea With Higher Parkinson’s Disease Risk
A new study found people with untreated obstructive sleep apnea could have an increased risk of developing Parkinson’s disease. Researchers
Novo Nordisk Says New Obesity Drug Helps Patients Lose Weight in Mid-Stage Trial
Novo Nordisk said a new weight-loss drug candidate led to weight loss and diabetes reductions in both injection and pill
Aggressive cancer warning signs revealed after JFK’s granddaughter’s diagnosis
NEWYou can now listen to Fox News articles! Days after Tatiana Schlossberg announced that she has terminal cancer, the spotlight
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET
Nutritionist says pumpkin has these surprising health benefits beyond holiday treats
NEWYou can now listen to Fox News articles! Pumpkin is a staple ingredient in many holiday dishes, like pumpkin pie,
Pumpkin’s secret health powers go far beyond the holidays, experts say
NEWYou can now listen to Fox News articles! Pumpkin is a staple ingredient in many holiday dishes, like pumpkin pie,
Health Care Roundup: Market Talk
Find insight on Novo Nordisk, Bayer, Samsung Biologics and more in the latest Market Talks covering the health care sector.
Novo Nordisk said a pill with the key ingredient in Ozempic and Wegovy didn’t slow Alzheimer’s disease in two late-stage clinical trials
Oral semaglutide—a key ingredient in obesity and diabetes drugs Ozempic and Wegovy—didn’t slow Alzheimer’s disease in two late-stage clinical trials.